Immatics IMTX
NASDAQ IMTX
$7.69 +0.18 (+2.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immatics (IMTX) EV to EBITDA (2022)

Updated

Immatics' (IMTX) EV to EBITDA was 6.72 for Q4 2022, down 45.7% from the prior quarter.

Analysis

Immatics (IMTX) EV to EBITDA (2022) Analysis & Trends

For FY2022, EV to EBITDA at Immatics was 7.35.

  • Per Business Quant data, the three quarters before Q4 2022 came in at 12.37 (Q3 2022), 9.70 (Q2 2022) and 22.06 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Immatics 939.02 Mn -1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 6.35
Sep 30, 2022 12.68
Jun 30, 2022 10.05
Mar 31, 2022 22.22
API Access

Immatics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IMTX&period=max&api_key=YOUR_API_KEY